1kba › Citations

Crystal structure of kappa-bungarotoxin at 2.3-A resolution.

Dewan JC, Grant GA, Sacchettini JC
Biochemistry 33 13147-54 (1994)
Cited: 40 times
EuropePMC logo PMID:
doi logo

Abstract

kappa-Neurotoxins display a very low affinity for neuromuscular receptors, but bind tightly to, and inhibit, nicotinic acetylcholine receptors in neuronal tissue such as the chick ciliary ganglia. In contrast, alpha-neurotoxins bind with high affinity and inhibit nicotinic acetylcholine receptors at the neuromuscular junction. The origin of this difference in specificity has been a long-studied question in the field. Here we report the first crystal structure of a kappa-neurotoxin, kappa-bungarotoxin. Unlike the NMR structure previously reported [Sutcliffe, M. J., Dobson, C. M., & Oswald, R. E. (1992) Biochemistry 31, 2962-2970], the present crystal structure more accurately defines the polypeptide fold and the nature of the interaction between subunits in the active dimer, which is a unique feature of the kappa-neurotoxins. The structure has been refined to R = 19.6% with X-ray diffraction data extending to a resolution of 2.3 A. There are two independent protein molecules (66 amino acid residues each) in the asymmetric unit that are arranged as a dimer with the two subunits related by a rotation of 178.6 degrees. Each subunit consists of three main-chain loops. Three of the five beta-strands of each subunit form an antiparallel beta-sheet which becomes an extended six-stranded antiparallel beta-sheet, by virtue of the approximate 2-fold symmetry of the dimer. The interactions at the dimer interface consist of six main-chain-main-chain hydrogen bonds, as well as three other hydrogen-bonding interactions involving side chains.(ABSTRACT TRUNCATED AT 250 WORDS)

Reviews - 1kba mentioned but not cited (3)

  1. Oliveira AL, Viegas MF, da Silva SL, Soares AM, Ramos MJ, Fernandes PA. Nat Rev Chem 6 451-469 (2022)
  2. Utkin YN. World J Biol Chem 10 17-27 (2019)
  3. Leth JM, Leth-Espensen KZ, Kristensen KK, Kumari A, Lund Winther AM, Young SG, Ploug M. Int J Mol Sci 20 E2760 (2019)

Articles - 1kba mentioned but not cited (4)

  1. Elcock AH, McCammon JA. Proc Natl Acad Sci U S A 98 2990-2994 (2001)
  2. Janin J, Rodier F, Chakrabarti P, Bahadur RP. Acta Crystallogr D Biol Crystallogr 63 1-8 (2007)
  3. Gilquin B, Bourgoin M, Ménez R, Le Du MH, Servent D, Zinn-Justin S, Ménez A. Protein Sci 12 266-277 (2003)
  4. Jiang Y, Lin L, Chen S, Jiang L, Kriegbaum MC, GÃ¥rdsvoll H, Hansen LV, Li J, Ploug M, Yuan C, Huang M. Int J Biol Sci 16 981-993 (2020)


Reviews citing this publication (10)

  1. Tsetlin V. Eur J Biochem 264 281-286 (1999)
  2. Doley R, Kini RM. Cell Mol Life Sci 66 2851-2871 (2009)
  3. Tsetlin VI. Trends Pharmacol Sci 36 109-123 (2015)
  4. Kumar TK, Jayaraman G, Lee CS, Arunkumar AI, Sivaraman T, Samuel D, Yu C. J Biomol Struct Dyn 15 431-463 (1997)
  5. Kessler P, Marchot P, Silva M, Servent D. J Neurochem 142 Suppl 2 7-18 (2017)
  6. Ponstingl H, Kabir T, Gorse D, Thornton JM. Prog Biophys Mol Biol 89 9-35 (2005)
  7. Tsetlin V, Utkin Y, Kasheverov I. Biochem Pharmacol 78 720-731 (2009)
  8. Chiappinelli VA, Weaver WR, McLane KE, Conti-Fine BM, Fiordalisi JJ, Grant GA. Toxicon 34 1243-1256 (1996)
  9. Reeks TA, Fry BG, Alewood PF. Cell Mol Life Sci 72 1939-1958 (2015)
  10. Bekbossynova A, Zharylgap A, Filchakova O. Molecules 26 3373 (2021)

Articles citing this publication (23)

  1. Bourne Y, Talley TT, Hansen SB, Taylor P, Marchot P. EMBO J 24 1512-1522 (2005)
  2. Bahadur RP, Chakrabarti P, Rodier F, Janin J. Proteins 53 708-719 (2003)
  3. Ponstingl H, Henrick K, Thornton JM. Proteins 41 47-57 (2000)
  4. Harvey SC, Luetje CW. J Neurosci 16 3798-3806 (1996)
  5. Ménez A. Toxicon 36 1557-1572 (1998)
  6. Pawlak J, Mackessy SP, Sixberry NM, Stura EA, Le Du MH, Ménez R, Foo CS, Ménez A, Nirthanan S, Kini RM. FASEB J 23 534-545 (2009)
  7. Sunagar K, Jackson TN, Undheim EA, Ali SA, Antunes A, Fry BG. Toxins (Basel) 5 2172-2208 (2013)
  8. Levy ED. Structure 15 1364-1367 (2007)
  9. Galat A, Gross G, Drevet P, Sato A, Ménez A. FEBS J 275 3207-3225 (2008)
  10. Roy A, Zhou X, Chong MZ, D'hoedt D, Foo CS, Rajagopalan N, Nirthanan S, Bertrand D, Sivaraman J, Kini RM. J Biol Chem 285 8302-8315 (2010)
  11. Maslennikov IV, Shenkarev ZO, Zhmak MN, Ivanov VT, Methfessel C, Tsetlin VI, Arseniev AS. FEBS Lett 444 275-280 (1999)
  12. Lyukmanova EN, Shenkarev ZO, Schulga AA, Ermolyuk YS, Mordvintsev DY, Utkin YN, Shoulepko MA, Hogg RC, Bertrand D, Dolgikh DA, Tsetlin VI, Kirpichnikov MP. J Biol Chem 282 24784-24791 (2007)
  13. Phui Yee JS, Nanling G, Afifiyan F, Donghui M, Siew Lay P, Armugam A, Jeyaseelan K. Biochimie 86 137-149 (2004)
  14. Shiu JH, Chen CY, Chang LS, Chen YC, Chen YC, Lo YH, Liu YC, Chuang WJ. Proteins 57 839-849 (2004)
  15. Aird SD, Womble GC, Yates JR, Griffin PR. Toxicon 37 609-625 (1999)
  16. Sine SM, Huang S, Li SX, daCosta CJ, Chen L. Biochem J 454 311-321 (2013)
  17. Chung C, Wu BN, Yang CC, Chang LS. Biol Chem 383 1397-1406 (2002)
  18. Girish VM, Kumar S, Joseph L, Jobichen C, Kini RM, Sivaraman J. PLoS One 7 e48112 (2012)
  19. Foo CS, Jobichen C, Hassan-Puttaswamy V, Dekan Z, Tae HS, Bertrand D, Adams DJ, Alewood PF, Sivaraman J, Nirthanan S, Kini RM. Br J Pharmacol 177 1822-1840 (2020)
  20. Chang LS, Chung C, Liou JC, Chang CW, Yang CC. Toxicon 42 323-330 (2003)
  21. Letter Liu M, Lin L, Høyer-Hansen G, Ploug M, Li H, Jiang L, Yuan C, Li J, Huang M. FEBS Lett 593 1236-1247 (2019)
  22. Talebzadeh-Farooji M, Amininasab M, Elmi MM, Naderi-Manesh H, Sarbolouki MN. Eur J Biochem 271 4950-4957 (2004)
  23. Xu J, Lei X, Li A, Li J, Li S, Chen L. Microb Cell Fact 23 48 (2024)


Quick links